Search Results for "Depuy Asr Trial In California Latest News"

03:47 EDT 5th September 2015 | BioPortfolio

Matching Channels

California encephalitis

California

In addition to the Silicon Valley, California on the west coast of the USA is home to a biotechnology hub. 26% of all American biotechnology firms are located in this state, but they count for over ...

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Clinical Trials Phase News

Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will norma...

Matching News

DePuy ASR Lawsuit News: Bernstein Liebhard LLP Comments on California Court’s Recent Order Extending Dismissal Statute for Cases Transferred to Federal Proceeding

New York, New York (PRWEB) March 09, 2015 A California Court overseeing hundreds of DePuy ASR hip lawsuits ( http://www.consumerinjurylawyers.com/DePuy/ ) filed in the state has issued an Order ext...

DePuy gains exclusive rights to market Radlink's imaging system

A global sales deal has been struck between DePuy Synthes and Radlink to allow DePuy to exclusively market Radlink's Galileo  -More- 

DePuy Synthes unveils new TFNA system

DePuy Synthes Companies of Johnson & Johnson has introduced new TFN-Advanced Proximal Femoral Nailing System (TFNA), developed to improve surgical treatment of hip fractures.

Health Highlights: July 1, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: California Governor Signs Tough Vaccination Bill Into Law California Governor Jerry Brown on Tue...

FDA labels DePuy Orthopaedics' femoral implants recall as Class II

A recall initiated by DePuy Orthopaedics involving different sizes of its LCS Complete RPS femoral implants has been labeled  -More- 

Health Highlights: April 10, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Record Number of West Nile Deaths In California Last Year The drought in California may have con...

J&J’s DePuy Synthes signs sales agreement with Radlink

Digital imaging equipment provider Radlink has entered into an exclusive worldwide sales agency agreement with Johnson & Johnson (J&J) subsidiary, DePuy Synthes Companies.

DePuy Synthes launches cellulose-based dural replacement for neurosurgery

DePuy Synthes CMF announced the launch of SYNTHECEL Dura Repair, the first commercially available biosynthesized dural replacement derived from cellulose for use in neurosurgery.

Matching PubMed Articles

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

Patients' preference to hear cancer diagnosis.

Bad news disclosure is one of the complex communication tasks of the physicians. Bad news is defined as:" any news that adversely and seriously affects an individual's view of his or her future". Rece...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement